交易中 02-05 10:11:09 美东时间
+1.525
+0.68%
FactSet Research Systems (FDS) declares $1.10/share quarterly dividend, in line with previous. Forward yield 1.95% Payable March 19; for shareholders of record Feb. 27; ex-div Feb. 27. See FDS Dividen...
今天 20:11
今日重点评级关注:韦德布什:维持Replimune Group"跑赢大市"评级,目标价从18美元升至19美元;巴克莱:维持CytomX Therapeutics"超配"评级,目标价从8美元升至10美元
今天 11:28
Wells Fargo analyst Jason Haas maintains FactSet Research Systems (NYSE:FDS) with a Underweight and lowers the price target from $265 to $215.
02-04 22:56
The most oversold stocks in the financial sector presents an opportunity to buy...
02-02 22:02
Barclays today announced a multiyear arrangement with FactSet (NYSE:FDS, NASDAQ:FDS), a global financial digital platform and enterprise solutions provider, as a further step in realizing Barclays' long-term market data
01-22 21:47
FactSet Secures Multiyear Strategic Agreement With Barclays FactSet Research Systems Inc. has entered into a multiyear strategic agreement with Barclays. Under this arrangement, Barclays will gain access to FactSet's suite of products, data, and technology solutions. The collaboration aims to enhanc
01-22 21:45
Barclays has entered into a multiyear partnership with FactSet to enhance its market data strategy. The collaboration will leverage FactSet's advanced analytics and technology to provide better data-driven solutions to Barclays' global clients. The partnership also reflects a shift where market data customers are increasingly becoming co-creators of capabilities. Barclays will join FactSet's Client Advisory Board, aiming to set new standards for ...
01-22 13:45
今日重点评级关注:HC Wainwright & Co.:维持Rezolve AI"买入"评级,目标价从10美元升至12美元;HC Wainwright & Co.:维持Largo"买入"评级,目标价从2.9美元升至3.1美元
01-15 16:10
今日重点评级关注:HC Wainwright & Co.:维持奥麦罗制药"买入"评级,目标价从20美元升至40美元;HC Wainwright & Co.:维持Cullinan Therapeutics"买入"评级,目标价从26美元升至27美元
01-09 20:22
Evercore ISI Group analyst David Motemeden maintains FactSet Research Systems (NYSE:FDS) with a In-Line and raises the price target from $320 to $321.
01-08 21:40